Targeting DLL-3 for a variety of potential lung cancer therapies
In this article, ACROBiosystems demonstrates how DLL-3 could become a potential target for a variety of lung cancer therapies.
Susan Winandy Nan Fang Alex Smith Martin Peter Proceedings Of The National Academy Sci Journal Of Southern Medical University
Source: news-medical.net